Phase I dose escalation and pharmacokinetic study of BI 2536, a novel Polo-like kinase 1 inhibitor, in patients with advanced solid tumors. (Q53443851)
Jump to navigation
Jump to search
scientific article published on 27 October 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I dose escalation and pharmacokinetic study of BI 2536, a novel Polo-like kinase 1 inhibitor, in patients with advanced solid tumors. |
scientific article published on 27 October 2008 |
Statements
Phase I dose escalation and pharmacokinetic study of BI 2536, a novel Polo-like kinase 1 inhibitor, in patients with advanced solid tumors. (English)
1 reference
Klaus Mross
1 reference
Annette Frost
1 reference
Simone Steinbild
1 reference
Susanne Hedbom
1 reference
Jochen Rentschler
1 reference
Rolf Kaiser
1 reference
Nicolas Rouyrre
1 reference
Dirk Trommeshauser
1 reference
Cornelia E Hoesl
1 reference
Gerd Munzert
1 reference
27 October 2008
1 reference
26
1 reference
5511-5517
1 reference
34
1 reference
Identifiers
1 reference